The Scandal Behind the FDA’s Fake Approval of the Pfizer Jab
The US Government regulator for drugs, the Food and Drug Administration, has just announced that it has voted full approval for the mRNA genetic vaccine of Pfizer and BioNTech, or did they? This supposed new status is being used by the Biden Administration and many states and companies to impose mandatory vaccinations. The notoriously conflicted Biden covid adviser, Tony Fauci of the NIAID, using that ruling, is calling for national mandatory vaccination for the country. What is not being revealed is the cesspool of corruption and conflicts of interest between the FDA and the major drug companies, including Pfizer, that stand behind the rushed approval. And it’s not full approval for Pfizer’s jab, only for BioNTech’s legally different vaccine. .
“…final stamp of approval”?
On August 23 as the FDA announced full approval for the Pfizer mRNA gene-edited substance. Or not quite, when the full papers of FDA are studied. Fauci, whose NIAID has financial interest in the vaccine, referred to the FDA decision as the “final stamp of approval.” It is however anything but final or an impartial, scientific rigorous medical evaluation. Rather it is a politically-motivated decision by an FDA that is corrupt beyond the imagination of most people.
Backtracking on its statement in 2020 that it would hold normal FDA advisory committee hearings with independent experts to discuss the Pfizer application for full approval, now the FDA told the British Medical Journal that they did not believe a meeting was necessary ahead of granting full approval of what is the most controversial vaccine in modern history. The BMJ quotes Kim Witczak, a drug safety advocate who serves as a consumer representative on the FDA’s Psychopharmacologic Drugs Advisory Committee, “These [FDA] public meetings are imperative in building trust and confidence especially when the vaccines came to market at lightning speed under emergency use authorization.”
Witczak continued with the alarming note, “It is already concerning that full approval is being based on 6 months’ worth of data despite the clinical trials designed for t
Article from LewRockwell